Interstitial lung disease: course report [PDF]
Breathe, 2020 The @EuroRespSoc course on ILD https://bit.ly/32PtzfH.
Michael Kreuter, Vitalii Poberezhets
openaire +2 more sources
Interstitial lung disease [PDF]
European Respiratory Review, 2013 This article reviews the most important articles published in interstitial lung disease, as reviewed during the Clinical Year in Review session at the 2012 annual European Respiratory Society Congress in Vienna, Austria.Since the recent international guidelines for the management of idiopathic pulmonary fibrosis (IPF), important new evidence is ...
openaire +4 more sources
In-hospital mortality following surgical lung biopsy for interstitial lung disease in the USA: 2000-2011 [PDF]
, 2016 Rationale: Surgical lung biopsy can help to determine a specific diagnosis in interstitial lung disease, but has associated risks. Most currently available mortality data are derived from case series and may not be generalizable to broader populations.
Fogarty, Andrew W. +3 more
core +1 more source
Lung transplantation for interstitial lung disease [PDF]
European Respiratory Review, 2021 Lung transplantation (LTx) can be a life-extending treatment option for patients with advanced and/or progressive fibrotic interstitial lung disease (ILD), especially idiopathic pulmonary fibrosis (IPF), fibrotic hypersensitivity pneumonitis, sarcoidosis and connective tissue disease-associated ILD.
Siddhartha G. Kapnadak, Ganesh Raghu
openaire +3 more sources
Palliative care for people with non-malignant lung disease: summary of current evidence and future direction [PDF]
, 2013 Background: The physical and psychosocial needs of patients with chronic non-malignant lung disease are comparable to those with lung cancer. This article will focus on chronic obstructive pulmonary disease, interstitial lung disease and cystic fibrosis ...
Boland, Jason +5 more
core +1 more source
Comorbidities in interstitial lung diseases
European Respiratory Review, 2017 Fibrosing lung disorders include a large number of diseases with diverse behaviour. Patients can die because of the progression of their illness, remain stable or even improve after appropriate treatment has been instituted.
George A. Margaritopoulos +2 more
doaj +1 more source
Surgical lung biopsy for the diagnosis of interstitial lung disease in England: 1997-2008 [PDF]
, 2016 Introduction: International guidelines and new targeted therapies for idiopathic pulmonary fibrosis have increased the need for accurate diagnosis of interstitial lung disease, which may lead to more surgical lung biopsies.
Fogarty, Andrew W. +4 more
core +2 more sources
Nintedanib for systemic sclerosis–associated interstitial lung disease [PDF]
, 2019 BackgroundInterstitial lung disease (ILD) is a common manifestation of systemic sclerosis and a leading cause of systemic sclerosis-related death. Nintedanib, a tyrosine kinase inhibitor, has been shown to have antifibrotic and antiinflammatory effects ...
Alves, Margarida +16 more
core +3 more sources
ERJ Open Research, 2021 Introduction Idiopathic pulmonary fibrosis (IPF) prognosis is heterogeneous despite antifibrotic treatment. Cluster analysis has proven to be a useful tool in identifying interstitial lung disease phenotypes, which has yet to be performed in IPF. The aim
Jaume Bordas-Martínez +10 more
doaj +1 more source
Connective tissue disease related interstitial lung diseases and idiopathic pulmonary fibrosis: provisional core sets of domains and instruments for use in clinical trials [PDF]
, 2013 Rationale Clinical trial design in interstitial lung diseases (ILDs) has been hampered by lack of consensus on appropriate outcome measures for reliably assessing treatment response.
Antoniou, K +40 more
core +1 more source